SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-277684
Filing Date
2019-10-29
Accepted
2019-10-29 16:02:21
Documents
13
Period of Report
2019-10-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d816474d8k.htm 8-K 24142
2 EX-99.1 d816474dex991.htm EX-99.1 21581
3 EX-99.2 d816474dex992.htm EX-99.2 27666
4 EX-99.3 d816474dex993.htm EX-99.3 7148
5 EX-99.4 d816474dex994.htm EX-99.4 10651
6 EX-99.5 d816474dex995.htm EX-99.5 14309
7 EX-99.6 d816474dex996.htm EX-99.6 19028
8 GRAPHIC g816474g04n65.jpg GRAPHIC 296258
9 GRAPHIC g816474g1029091016637.jpg GRAPHIC 2535
10 GRAPHIC g816474g57h96.jpg GRAPHIC 355246
11 GRAPHIC g816474g68z43.jpg GRAPHIC 310130
12 GRAPHIC g816474g74u03.jpg GRAPHIC 3423
13 GRAPHIC g816474g78o58.jpg GRAPHIC 294628
  Complete submission text file 0001193125-19-277684.txt   1865304
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 191176330
SIC: 2834 Pharmaceutical Preparations